Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussion reflects a moderate but attentive engagement with the case report, with examples like users noting the symptom onset after drug addition and emphasizing the importance of understanding drug interactions; words like 'important,' 'link,' and 'clinical implications' illustrate a responsible tone that underscores the relevance of the findings.
Most discussion participants agree that the case report highlights an important drug interaction concern, as seen in comments supporting the link between celecoxib and jitteriness symptoms.
The discussions show moderate interest, with users expressing curiosity about the clinical implications and potential side effects, but not deeply exploring mechanistic details.
Participants are actively discussing the case, referencing the timeline of symptom resolution and possible mechanisms, indicating a moderate level of engagement.
The discussions suggest that this report could influence clinical awareness and prescribing practices, highlighting its potential significance for healthcare providers.
New Case report: Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis https://t.co/MH6Bh41qod
A woman in her 60s experienced jitteriness-anxiety syndrome after taking celecoxib with her antidepressants, escitalopram and trazodone. Symptoms resolved after stopping celecoxib, highlighting potential interactions…
New Case report: Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis https://t.co/MH6Bh41qod